Diterpenoid DGT Alleviates Atopic Dermatitis–Like Responses In Vitro and In Vivo via Targeting IL-4Rα

Researchers observed anti-inflammatory effects of DGT on tumor necrosis factor-α/interferon-γ–treated human keratinocytes, and anti-allergic effects on immunoglobulin E–sensitized bone marrow–derived mast cells.